Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Safeguard Scientifics Inc is an asset management business based in the US. Safeguard Scientifics shares (SFE) are listed on the NYSE and all prices are listed in US Dollars.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $6.53 |
|---|---|
| 52-week range | $5.95 - $8.98 |
| 50-day moving average | $7.43 |
| 200-day moving average | $7.54 |
| Wall St. target price | $16.00 |
| PE ratio | 5.1645 |
| Dividend yield | N/A (17.99%) |
| Earnings per share (TTM) | $1.36 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $6.53 from 2022-01-21
| 1 week (2022-01-14) | -6.71% |
|---|---|
| 1 month (2021-12-23) | -0.15% |
| 3 months (2021-10-22) | -21.89% |
| 6 months (2021-07-23) | -14.97% |
| 1 year (2021-01-22) | -4.25% |
|---|---|
| 2 years (2020-01-23) | -40.74% |
| 3 years (2019-01-23) | 9.85 |
| 5 years (2017-01-23) | 12.15 |
Valuing Safeguard Scientifics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Safeguard Scientifics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Safeguard Scientifics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, Safeguard Scientifics shares trade at around 5x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -3.86% |
| Return on equity TTM | 3362.82% |
| Profit margin | 0% |
| Book value | $4.71 |
| Market capitalisation | $115.5 million |
TTM: trailing 12 months
We're not expecting Safeguard Scientifics to pay a dividend over the next 12 months.
Safeguard Scientifics's shares were split on a 1:6 basis on 26 August 2009. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Safeguard Scientifics shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Safeguard Scientifics shares which in turn could have impacted Safeguard Scientifics's share price.
Over the last 12 months, Safeguard Scientifics's shares have ranged in value from as little as $5.95 up to $8.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Safeguard Scientifics's is 0.9549. This would suggest that Safeguard Scientifics's shares are less volatile than average (for this exchange).
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services.
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.